Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Researchers say GLP-1 medicines might be able to help with migraines.

Key Takeaways Tirzepatide may be more effective than semaglutide or liraglutide for weight loss, as it has a dual mechanism of action. Semaglutide has the longest half-life of the three, which may ...

Liraglutide, an analogue of human glucagon-like peptide 1 (GLP-1), 6 has been approved for the treatment of type 2 diabetes. Its efficacy in lowering glucose levels has been established, and it ...

The glucagon-like peptide-1 (GLP-1) analogues liraglutide and semaglutide are approved by the Food and Drug Administration and the European Medicines Agency for long-term weight management in ...

Liraglutide has been previously shown to increase bone formation and prevent bone loss in obese women who have lost weight.. For this new study, 195 obese participants shed at least 5% of their ...

Liraglutide is an analog with 97% homology to human glucagon-like peptide (GLP-1) and acts as a GLP-1 receptor agonist. Several large, randomized, multicenter phase 3 trials evaluated the efficacy ...

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, an injection used to control blood sugar levels of type 2 diabetics, but it’s also approved for weight loss for use in ...

Children who used the weight loss drug liraglutide in a late-stage trial lost significantly more weight than children who got a placebo, according to a new study. CNN values your feedback 1.